COVID-19 vaccine trials are being undermined by a lack of diversity

{ object.primary_image.title }}

To make sure a vaccine works for everyone, everyone needs to be in the trials. At least 10 COVID-19 vaccines are currently in the final phase of their trials, where the vaccine is given to thousands of people to test its safety and efficacy. But as the quest for a coronavirus vaccine continues, experts say there’s still an issue with how diverse these trials are, which could impact how effective a vaccine is for everyone. Read Full Story

More

How to get a COVID-19 vaccine by volunteering

{ object.primary_image.title }}

As vaccination sites expand, states need volunteers to help with the logistics of vaccinating the masses. Psssst. Are you eagerly seeking a COVID-19 vaccine but are not yet eligible in your state? There’s one possible path to getting that priceless stab in your arm that you can feel good about: Volunteering at a vaccination site, which could make you a frontline worker and therefore immediately eligible. Read Full Story

More

AstraZeneca’s COVID-19 vaccine has 79% efficacy in new U.S.-based trial

{ object.primary_image.title }}

The latest Phase III trial encompassed 32,000 participants, 21,583 of those receiving at least one dose of the AstraZeneca vaccine. The beleaguered AstraZeneca COVID-19 vaccine got a big shot in the arm, so to speak, today with results of the latest clinical trial which showed the vaccine is 79% effective against the virus. Previous studies pegged the AstraZeneca vaccine with an efficacy of 67%. Best of all, the latest trials reconfirmed what earlier ones did: AstraZeneca’s vaccine is 100% effective at preventing severe disease and hospitalization from COVID-19. Read Full Story

More

How many COVID-19 vaccines it will take to stop the pandemic, explained by a scientist

{ object.primary_image.title }}

A computational biologist breaks down estimates of the critical vaccination level, which can help predict when life can start to return to normal. It has been clear for a while that, at least in the U.S., the only way out of the coronavirus pandemic will be through vaccination. The rapid deployment of coronavirus vaccines is underway, but how many people need to be vaccinated in order to control this pandemic? Read Full Story

More

This company is preparing to manufacture 100 million doses of COVID-19 vaccines

{ object.primary_image.title }}

The pharmaceutical company Sanofi is retrofitting current manufacturing facilities so they’ll be able to pump out millions of COVID-19 vaccine doses when it is finally developed. There are 76 vaccine candidates for COVID-19, five of which are in clinical trials. It will take at least 18 months to determine if these vaccines are effective and safe enough to distribute en masse. Then, distributing them to millions of people will require an incredible feat of manufacturing. Read Full Story

More

Can we pay people to get them to take the coronavirus vaccine? Here’s why it might not work

{ object.primary_image.title }}

There’s a growing moment to tie a government stimulus to vaccine rollout. These health law professors argue it’s not feasible and might exacerbate vaccine mistrust. The first COVID-19 vaccine to gain emergency use authorization in the U.S. could roll out within days, as Pfizer and BioNTech’s candidate was endorsed by an external advisory panel to the Food and Drug Administration on December 10. Two days earlier, an internal FDA panel endorsed the vaccine. These were the last required steps before the FDA authorizes the vaccine, which will soon be administered to healthcare workers across the country. Read Full Story

More

Subscribe to our newsletter

Join our newsletter and never miss out trending marketing news.

HitcountVariables(pk=11483, ajax_url='/api/hit/ajax/', hits='2')